Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.

Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.

Nefrologia. 2017 Sep - Oct;37(5):531-538. doi: 10.1016/j.nefro.2016.11.017. English, Spanish.

2.

Study of the variables associated with local complement activation in IgA nephropathy.

Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.

Nefrologia. 2017 May - Jun;37(3):320-329. doi: 10.1016/j.nefro.2016.11.019. Epub 2017 May 8. English, Spanish.

3.

Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.

Jatem Escalante E, Segarra Medrano A, Carnicer Cáceres C, Martín-Gómez MA, Salcedo Allende MT, Ostos Roldan H, Agraz Pamplona I.

Nefrologia. 2015;35(5):479-86. doi: 10.1016/j.nefro.2015.05.026. Epub 2015 Jul 7. English, Spanish.

4.

Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.

Segarra-Medrano A, Jatem-Escalante E, Carnicer-Cáceres C, Agraz-Pamplona I, Salcedo MT, Valtierra N, Ostos-Roldán E, Arredondo KV, Jaramillo J.

Nefrologia. 2014;34(4):491-7. doi: 10.3265/Nefrologia.pre2014.Jun.12536. English, Spanish.

5.

Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.

Segarra-Medrano A, Jatem-Escalante E, Quiles-Pérez MT, Salcedo MT, Arbós-Via MA, Ostos H, Valtierra N, Carnicer-Cáceres C, Agraz-Pamplona I.

Nefrologia. 2014 May 21;34(3):353-9. doi: 10.3265/Nefrologia.pre2013.Dec.12291. Epub 2014 Feb 10. English, Spanish.

6.

Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors.

Segarra-Medrano A, Jatem-Escalante E, Agraz-Pamplona I, Carnicer-Cáceres C, Ramos-Terrades N, Ostos-Roldán E, Quiles-Pérez MT, Arbós-Via MA.

Nefrologia. 2013;33(4):448-61. doi: 10.3265/Nefrologia.pre2013.Jan.11871. Review. English, Spanish.

7.

Biological markers of nephrotic syndrome: a few steps forward in the long way.

Segarra-Medrano A, Carnicer-Cáceres C, Arbós-Via MA, Quiles-Pérez MT, Agraz-Pamplona I, Ostos-Roldán E.

Nefrologia. 2012;32(5):558-72. doi: 10.3265/Nefrologia.pre2012.Jun.11396. Review. English, Spanish.

8.

[Treatment with rituximab for a patient with p-ANCA glomerulonephritis, alveolar bleeding and multiple relapses during haemodialysis].

Azancot MA, Agraz Pamplona I, Fort Ros J, Marín Valencia A, Gil Carballeira I, Camps Domenech J.

Nefrologia. 2010;30(6):710-2. doi: 10.3265/Nefrologia.pre2010.Aug.10535. Spanish. No abstract available.

9.

[Study of the clinically useful interval in ambulatory monitoring of blood pressure].

Mora-Maciá J, Agraz Pamplona I, Ocón Pujadas J, Barceló P.

Med Clin (Barc). 1997 Feb 22;108(7):248-53. Spanish.

PMID:
9121192

Supplemental Content

Loading ...
Support Center